Blackstone’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171K Buy
+11,754
New +$208K ﹤0.01% 513

Other funds holding SMMT

Blackstone's SMMT Position: Q2 2026 in Review

Blackstone opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 11,754 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #513 among its holdings.

243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Blackstone held 11,754 shares of Summit Therapeutics worth $171K as of Q2 2026.
  • Summit Therapeutics was a new Blackstone position in Q2 2026.
  • Summit Therapeutics made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #513 holding.
  • 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.